» Articles » PMID: 33588913

A Specific TRNA Half, 5'tiRNA-His-GTG, Responds to Hypoxia Via the HIF1α/ANG Axis and Promotes Colorectal Cancer Progression by Regulating LATS2

Overview
Publisher Biomed Central
Specialty Oncology
Date 2021 Feb 16
PMID 33588913
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Currently, tRNA-derived small RNAs (tsRNAs) are recognized as a novel and potential type of non-coding RNAs (ncRNAs), which participate in various cellular processes and play an essential role in cancer progression. However, tsRNAs involvement in colorectal cancer (CRC) progression remains unclear.

Methods: Sequencing analyses were performed to explore the tsRNAs with differential expression in CRC. Gain- and loss-of functions of 5'tiRNA-His-GTG were performed in CRC cells and xenograft tumor to discover its role in the progression of CRC. Hypoxia culture and hypoxia inducible factor 1 subunit alpha (HIF1α) inhibitors were performed to uncover the biogenesis of 5'tiRNA-His-GTG. The regulation of 5'tiRNA-His-GTG for large tumor suppressor kinase 2 (LATS2) were identified by luciferase reporter assay, western blot, and rescue experiments.

Results: Here, our study uncovered the profile of tsRNAs in human CRC tissues and confirmed a specific tRNA half, 5'tiRNA-His-GTG, is upregulated in CRC tissues. Then, in vitro and in vivo experiments revealed the oncogenic role of 5'tiRNA-His-GTG in CRC and found that targeting 5'tiRNA-His-GTG can induce cell apoptosis. Mechanistically, the generation of 5'tiRNA-His-GTG seems to be a responsive process of tumor hypoxic microenvironment, and it is regulated via the HIF1α/angiogenin (ANG) axis. Remarkably, LATS2 was found to be an important and major target of 5'tiRNA-His-GTG, which renders 5'tiRNA-His-GTG to "turn off" hippo signaling pathway and finally promotes the expression of pro-proliferation and anti-apoptosis related genes.

Conclusions: In summary, the findings revealed a specific 5'tiRNA-His-GTG-engaged pathway in CRC progression and provided clues to design a novel therapeutic target in CRC.

Citing Articles

New insights into tRNA-derived small RNAs in human digestive diseases.

Liu Y, Chen F, Zhang F, Ye Y, Su Y, Liu Y Mol Biol Rep. 2025; 52(1):295.

PMID: 40063289 DOI: 10.1007/s11033-025-10393-7.


Combinatorial Analysis of miRNAs and tRNA Fragments as Potential Biomarkers for Cancer Patients in Liquid Biopsies.

Glogovitis I, DAmbrosi S, Antunes-Ferreira M, Chiogna M, Yahubyan G, Baev V Noncoding RNA. 2025; 11(1).

PMID: 39997617 PMC: 11858735. DOI: 10.3390/ncrna11010017.


Identification and potential mechanism of a novel gastric cancer suppressor tRF-24-6VR8K09LE9.

Tang Y, Ni K, Jin K, Feng W, Ju S, Jing R Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39992418 DOI: 10.1007/s00210-025-03914-5.


tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer.

Zhang B, Pan Y, Li Z, Hu K J Transl Med. 2025; 23(1):51.

PMID: 39806419 PMC: 11727791. DOI: 10.1186/s12967-025-06109-x.


Co-targeting of glial activation and inflammation by tsRNA-Gln-i-0095 for treating retinal ischemic pathologies.

Zhang Y, Ma Y, Ji Y, Jiang Y, Li D, Mu W Cell Commun Signal. 2025; 23(1):18.

PMID: 39794828 PMC: 11721595. DOI: 10.1186/s12964-024-02013-x.


References
1.
Vaupel P, Hockel M, Mayer A . Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal. 2007; 9(8):1221-35. DOI: 10.1089/ars.2007.1628. View

2.
Goncalves K, Silberstein L, Li S, Severe N, Hu M, Yang H . Angiogenin Promotes Hematopoietic Regeneration by Dichotomously Regulating Quiescence of Stem and Progenitor Cells. Cell. 2016; 166(4):894-906. PMC: 4988404. DOI: 10.1016/j.cell.2016.06.042. View

3.
Tao E, Cheng W, Li W, Yu J, Gao Q . tiRNAs: A novel class of small noncoding RNAs that helps cells respond to stressors and plays roles in cancer progression. J Cell Physiol. 2019; 235(2):683-690. DOI: 10.1002/jcp.29057. View

4.
Li S, Shi X, Chen M, Xu N, Sun D, Bai R . Angiogenin promotes colorectal cancer metastasis via tiRNA production. Int J Cancer. 2019; 145(5):1395-1407. DOI: 10.1002/ijc.32245. View

5.
Huang B, Yang H, Cheng X, Wang D, Fu S, Shen W . tRF/miR-1280 Suppresses Stem Cell-like Cells and Metastasis in Colorectal Cancer. Cancer Res. 2017; 77(12):3194-3206. DOI: 10.1158/0008-5472.CAN-16-3146. View